Literature DB >> 15913738

Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.

David E Cohn1, Carl D Morrison, Vanna L Zanagnolo, Melissa M Goist, Larry J Copeland.   

Abstract

BACKGROUND: Cervical adenocarcinoma in situ is often diagnosed in younger women who may wish to preserve the potential for fertility. Given that the rate of recurrent adenocarcinoma in situ is relatively low and the risk of invasive adenocarcinoma is extremely rare, conservative management in this population after a cone biopsy demonstrates negative margins has been accepted as an appropriate management strategy. This case challenges the concept of conservative management of cervical adenocarcinoma in situ. CASE: A 42-year-old G2P2002 with previously normal annual cervical cytology had a Pap smear demonstrating atypical glandular cells of uncertain significance. A 1.5-cm lesion was noted at the endocervix, and a punch biopsy revealed adenocarcinoma in situ. A large cold knife cone biopsy confirmed cervical adenocarcinoma in situ with negative margins. Definitive therapy for in situ disease with an extrafascial hysterectomy was performed 12 days after conization, and demonstrated stage IB1 cervical adenocarcinoma. A radical parametrectomy, radical upper vaginectomy, and pelvic lymphadenectomy were without persistent disease.
CONCLUSION: Conservative management of cervical adenocarcinoma in situ after a cone biopsy with negative margins does not exclude the possibility of concurrent invasive cervical adenocarcinoma. This case challenges the current balance between risk and benefit associated with the conservative management of cervical adenocarcinoma in situ.

Entities:  

Mesh:

Year:  2005        PMID: 15913738     DOI: 10.1016/j.ygyno.2005.04.013

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice.

Authors:  M Origoni; P Cristoforoni; S Costa; L Mariani; P Scirpa; A Lorincz; M Sideri
Journal:  Ecancermedicalscience       Date:  2012-06-18

Review 2.  Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.

Authors:  Silvano Costa; Simona Venturoli; Massimo Origoni; Mario Preti; Luciano Mariani; Paolo Cristoforoni; Maria Teresa Sandri
Journal:  Ecancermedicalscience       Date:  2015-04-29

3.  Oncological and reproductive outcomes of adenocarcinoma in situ of the cervix managed with the loop electrosurgical excision procedure.

Authors:  Huimin Bai; Jun Liu; Qiuxi Wang; Ying Feng; Tong Lou; Shuzhen Wang; Yue Wang; Mulan Jin; Zhenyu Zhang
Journal:  BMC Cancer       Date:  2018-04-24       Impact factor: 4.430

4.  Oncologic and obstetric outcomes after conization for adenocarcinoma in situ or stage IA1 cervical cancer.

Authors:  Xiaoyu Wang; Yalan Bi; Huanwen Wu; Ming Wu; Lei Li
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.